February 3, 2022
PAR-22-064 - Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional)
National Cancer Institute (NCI)
The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) is participating, effective immediately, in Funding Opportunity Announcement (FOA) PAR-22-064,"Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional)".
The following sections of PAR-22-064 have been modified (see text added in bold italics) to highlight NCI’s participation in this FOA:
Part 1. Overview Information
Components of Participating Organizations
National Institute on Minority Health and Health Disparities (NIMHD)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute on Deafness and Other Communication Disorders (NIDCD)
All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.
Sexual and Gender Minority Research Office (SGMRO)
Office of Research on Women's Health (ORWH)
National Cancer Institute (NCI)
Assistance Listing Number(s)
93.307, 93.846, 93.173, 93.313, 93.393
Part 2. Full Text of Announcement
Section I. Funding Opportunity Description
Other Participating Institutes/Centers/Offices Areas of Research Interest
The following paragraph has been added after Office for Research on Women's Health (ORWH)'s Areas of Research Interest
National Cancer Institute (NCI)
Division of Cancer Control & Population Sciences (DCCPS)
The mission of the NCI Division of Cancer Control & Population Sciences (DCCPS) is to reduce risk, incidence, and deaths from cancer as well as enhance the quality of life for cancer survivors. DCCPS is interested in supporting research that advances knowledge about factors influencing PCR and interventions that enhance PCR and outcomes related to cancer prevention, screening, diagnosis, treatment, and survivorship among populations that experience health disparities. Applications to DCCPS are encouraged to address intersections or interactions among factors at two or more levels (e.g., patient, caregiver, clinician, practice, health system, community, policy) relevant to patient-clinician relationships and related outcomes. DCCPS also includes genetic counselors in the definition of clinicians (See key definitions section). Research areas of interest to DCCPS include, but are not limited to, studies that:
Division of Cancer Prevention (DCP)
The NCI Division of Cancer Prevention (DCP) leads, supports, and promotes rigorous, innovative research and training to prevent cancer and its consequences, to improve the health of all people. DCP is interested in research that promotes communication, shared decision-making, and strengthens PCR to address cancer health disparities and improve outcomes related to cancer prevention, screening, cancer symptomatology, and treatment related toxicities along the cancer care continuum. DCP is also interested in innovative studies that enhance enrollment of underrepresented populations to NCI supported clinical trials with a focus on improved communication among patients, caregivers and clinicians and interdisciplinary teams and specialists; shared decision-making; and PCR.Research areas of interest to DCP include, but are not limited to, studies that:
Section VII. Agency Contacts
Scientific/Research Contact(s)
Larissa Aviles-Santa, MD, MPH
National Institute on Minority Health and Health Disparities (NIMHD)
Telephone: 301-827-6924
Email: avilessantal@nih.gov
Xincheng (Ted) Zheng, MD, PhD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Phone: 301-594-4953
E-mail: zhengx4@mail.nih.gov
Howard J. Hoffman
National Institute on Deafness and Other Communication Disorders (NIDCD)
Phone: 301-402-1843
E-mail: hoffmanh@ms.nidcd.nih.gov
Damiya Eve Whitaker
Office Of Research on Women's Health (ORWH)
Phone: 240-276-6170
E-mail: damiya.whitaker@nih.gov
Christopher Barnhart, PhD
Sexual & Gender Minority Research Office (SGMRO)
Telephone: 301-594-8983
Email: christopher.barnhart@nih.gov
Sallie J. Weaver, PhD MHS
National Cancer Institute (NCI)
Telephone: 240-276-6254
Email: sallie.weaver@nih.gov
Amanda Acevedo, PhD
National Cancer Institute (NCI)
Telephone: 240-276-5896
Email: amanda.acevedo@nih.gov
Diane St. Germain, RN, MS, CRNP
National Cancer Institute (NCI)
Telephone: 240-276-7050
Email: dstgermain@mail.nih.gov
Financial/Grants Management Contact(s)
Priscilla Grant, JD
National Institute on Minority Health and Health Disparities (NIMHD)
Telephone: 301-594-8412
Email: grantp@mail.nih.gov
Erik Edgerton
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Phone: 301-594-7760
E-mail: erik.edgerton@nih.gov
Christopher Myers
National Institute on Deafness and Other Communication Disorders (NIDCD)
Phone: (301) 435-0713
E-mail: myersc@nih.gov
Crystal Wolfrey
National Cancer Institute (NCI)
Telephone: 240-276-6277
Email: wolfreyc@mail.nih.gov
All other aspects of this FOA remain unchanged.
Sallie J. Weaver, PhD, MHS
National Cancer Institute (NCI)
Telephone: 240-276-6254
Email: sallie.weaver@nih.gov